Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.3K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical treatment of a congenital rectal cystic hamartoma in a 20-day Kurdish foal.

Veterinary research forum : an international quarterly journal·2026
Same author

The effect of a program for improving positivity skill on perceived stress among patients with chronic heart failure.

Journal of education and health promotion·2026
Same author

An international cohort study of breast cancer survival in young women.

BJC reports·2026
Same author

The effect of a positive psychology skill enhancement program on the sense of well-being in patients with chronic heart failure.

BMC psychology·2026
Same author

Corrigendum to "Exosomes in Alzheimer's disease: From pathogenesis to therapeutics - A comprehensive review of diagnostic and drug delivery applications" [Biomed. Pharmacother. 192 (2025) 118548].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

The needs of the family caregivers of patients with end-stage chronic obstructive pulmonary disease: a qualitative study in Iran.

BMC nursing·2025

Related Experiment Video

Updated: Sep 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K

Drug-target interaction/affinity prediction: Deep learning models and advances review.

Ali Vefghi1, Zahed Rahmati1, Mohammad Akbari1

  • 1Department of Mathematics and Computer Science, Amirkabir University of Technology, Tehran, Iran.

Computers in Biology and Medicine
|July 3, 2025
PubMed
Summary

Deep learning models accelerate drug discovery by improving drug-target interaction prediction. This review analyzes 180 machine learning methods to enhance the efficiency of developing life-saving medications.

Keywords:
Drug discoveryDrug-target affinity predictionDrug-target interaction prediction

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

665

Related Experiment Videos

Last Updated: Sep 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

665

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Artificial intelligence in drug discovery

Background:

  • Drug discovery is a lengthy, costly, and safety-concerned process.
  • Traditional methods struggle with complex drug-target relationships.
  • Accurate prediction of drug-target interactions is crucial for faster drug development.

Purpose of the Study:

  • To provide researchers with an overview of advanced methods for predicting drug-target interaction and affinity.
  • To highlight promising research avenues and models in this field.
  • To accelerate the development of more effective drugs.

Main Methods:

  • Analysis of 180 drug-target interaction/affinity prediction methods from 2016-2025.
  • Focus on machine learning, particularly deep learning and graph neural networks.
  • Discussion of model novelty, architecture, and input representation.

Main Results:

  • Deep learning models show significant potential in overcoming limitations of traditional methods.
  • Identified various frameworks and approaches for precise and efficient interaction prediction.
  • Comprehensive analysis covers a decade of research in computational drug discovery.

Conclusions:

  • Deep learning and graph neural networks are key to advancing drug-target interaction prediction.
  • Further research in these areas can significantly speed up the delivery of novel therapeutics.
  • This review serves as a guide for researchers seeking to improve drug discovery efficiency.